![](/wp-content/uploads/2023/02/Screenshot-2023-02-22-at-10.24.34-PM.png)
$599
Ionis Q4 ’22 Earnings; ATTD 2023 Key Press Releases
A series of cardiometabolic-related news items have been observed from Ionis, Dexcom, Ypsomed, Amgen, and MannKind. Below, FENIX provides highlights and insights into the respective news items.